Ghent University Academic Bibliography

Advanced

123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction

Bart Cornelissen, Katrien Remaut UGent, Veerle Kersemans, Ruth Oltenfreiter UGent, Ingrid Burvenich and Guido Slegers UGent (2004) EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 31(suppl. 2). p.S391-S391
Please use this url to cite or link to this publication:
author
organization
year
type
conference
publication status
published
subject
in
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Eur. J. Nucl. Med. Mol. Imaging
volume
31
issue
suppl. 2
pages
S391 - S391
conference name
2004 European Association of Nuclear Medicine annual congress (EANM 2004)
conference location
Helsinki, Finland
conference start
2004-09-05
conference end
2004-09-08
JCR category
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
JCR impact factor
3.935 (2004)
JCR rank
7/84 (2004)
JCR quartile
1 (2004)
ISSN
1619-7070
language
English
UGent publication?
yes
classification
C3
id
300515
handle
http://hdl.handle.net/1854/LU-300515
date created
2005-03-23 15:35:00
date last changed
2016-12-19 15:35:40
@inproceedings{300515,
  author       = {Cornelissen, Bart and Remaut, Katrien and Kersemans, Veerle and Oltenfreiter, Ruth and Burvenich, Ingrid and Slegers, Guido},
  booktitle    = {EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING},
  issn         = {1619-7070},
  language     = {eng},
  location     = {Helsinki, Finland},
  number       = {suppl. 2},
  pages        = {S391--S391},
  title        = {123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction},
  volume       = {31},
  year         = {2004},
}

Chicago
Cornelissen, Bart, Katrien Remaut, Veerle Kersemans, Ruth Oltenfreiter, Ingrid Burvenich, and Guido Slegers. 2004. “123I-EGF Internalisation in Tumour Cells in Vitro Is Inhibited by Farnesyltransferase Inhibitor Therapy: Possible Target for Early Therapy Response Prediction.” In European Journal of Nuclear Medicine and Molecular Imaging, 31:S391–S391.
APA
Cornelissen, B., Remaut, K., Kersemans, V., Oltenfreiter, R., Burvenich, I., & Slegers, G. (2004). 123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (Vol. 31, pp. S391–S391). Presented at the 2004 European Association of Nuclear Medicine annual congress (EANM 2004).
Vancouver
1.
Cornelissen B, Remaut K, Kersemans V, Oltenfreiter R, Burvenich I, Slegers G. 123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2004. p. S391–S391.
MLA
Cornelissen, Bart, Katrien Remaut, Veerle Kersemans, et al. “123I-EGF Internalisation in Tumour Cells in Vitro Is Inhibited by Farnesyltransferase Inhibitor Therapy: Possible Target for Early Therapy Response Prediction.” European Journal of Nuclear Medicine and Molecular Imaging. Vol. 31. 2004. S391–S391. Print.